ProMIS Neurosciences, Inc. (PMN:NASDAQ) closed at $8.34 on October 23, 2026, down 7.54% on the day. The stock trades 69.6% below its 52-week high of $27.40 and 33.0% above its 52-week low of $6.27. Over the past year, it lost 22.4%. ProMIS Neurosciences, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, PMN closed higher on 114 days (45%). Its best day was July 28, 2026 (+23.89%) and its worst was November 24, 2025 (-21.43%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 2 times.
ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It primarily operates in Canada.
Find more stocks like PMN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.